In the long human struggle against cancer, a new chapter is being written — not with chemicals that poison indiscriminately, but with a therapy that teaches the body's own defenses to recognize and destroy what does not belong. Fifteen patients with advanced, treatment-resistant head and neck cancers, having exhausted every conventional option, experienced complete tumor elimination after receiving amivantamab in an international trial. Presented at the American Society of Clinical Oncology in Chicago, the findings do not yet constitute a cure, but they represent something rarer and more fragi
InfoMoney
· May 30, 2026
· health
· 2 min de leitura
High
Apuração: Verificado
Experimental immunotherapy achieves complete tumor elimination in 15 advanced cancer patients
15 patients with previously untreatable advanced cancers experienced complete tumor elimination, with one patient regaining ability to eat and speak normally.
◉
Health & Medicine
2792 artigos relacionados
Ozempic and GLP-1 drugs: how the weight-loss revolution works and what…
O GLOBO · 99% correspondência
Medical Expert Warns of Tirzepatide Risks, Emphasizes Need for Profess…
UNIPAR · 90% correspondência
Berlin admits American Ebola patient as outbreak kills 131 in Congo
Folha de S.Paulo · 90% correspondência
Anvisa aprova remdesivir contra covid-19 e registra vacina de Oxford
Jornal de Brasília · 90% correspondência
Brazil Gets New Blood Test for Early Alzheimer's Detection
Olhar Digital · 90% correspondência
Cobertura Relacionada
O POVO · Aug 23
Dia D mobiliza Fortaleza com multivacinação e mutirão bucal em 264 locais
Fortaleza realizou mobilização massiva de imunização com 3 mil profissionais em 264 locais, incluindo multivacinação, mu…
Folha de S.Paulo · Aug 23 Tratar apneia do sono pode reduzir pressão arterial em hipertensosEstudo brasileiro demonstra que tratar apneia obstrutiva do sono contribui para reduzir hipertensão resistente, mesmo em…
Rádio Pampa · Aug 23 Duas em cada três pessoas com Alzheimer são mulheres; sintomas podem começar aos 45Pesquisa mostra que duas em cada três pessoas com Alzheimer são mulheres, com sintomas podendo começar aos 45 anos devid…
Rádio Pampa · Aug 23 Dieta rica em vegetais reduz risco de doença renal crônica, aponta estudoEstudo com 179.508 participantes mostra que dieta rica em vegetais, frutas e grãos integrais reduz risco de doença renal…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Medical breakthrough in cancer immunotherapy has no direct geopolitical implications; this is a clinical advancement with potential humanitarian benefits across nations.
Escalation Risk
low
Confidence
HIGH
No power dynamics shifts. This is a health/science matter with international collaboration (11 countries) that transcends geopolitical competition.
Lente Econômica
📈
Experimental immunotherapy (amivantamab) shows promising results eliminating tumors in advanced cancer patients, with potential to expand pharmaceutical market and reduce healthcare costs through improved treatment options.
Market Signal
bullish
Confidence
MED
Pharmaceutical and Biotechnology
Healthcare and Medical Services
Medical Devices and Diagnostics
Health Insurance
Hospital and Clinical Services
Patients with treatment-resistant advanced cancers gain access to potentially life-extending therapy, improving quality of life and survival rates. However, costs may be high initially, potentially affecting healthcare affordability until broader adoption and competition reduce prices.
Regulatory agencies (FDA, EMA, ANVISA in Brazil) will likely accelerate approval pathways for promising immunotherapies. Healthcare systems may need to adjust reimbursement policies and budget allocations for expensive cancer treatments. Patent and intellectual property considerations will influence market competition and drug pricing.